"Orphan Drug" - Google News

pCPA receives FDA Orphan Drug Designation for monoamine oxidase deficiency - Contemporary Pediatrics

Tue, 16 Jun 2026 13:42:33 GMT

pCPA receives FDA Orphan Drug Designation for monoamine oxidase deficiency Contemporary Pediatrics

Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas - BioSpace

Tue, 16 Jun 2026 13:50:26 GMT

Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas BioSpace

ALKS' Sleep Disorder Drug Gets Orphan Drug Tags in the U.S. & Europe - Yahoo Finance

Tue, 16 Jun 2026 14:15:00 GMT

ALKS' Sleep Disorder Drug Gets Orphan Drug Tags in the U.S. & Europe Yahoo Finance

GSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome - GSK

Fri, 12 Jun 2026 10:46:32 GMT

GSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome GSK

Mabion Enters Rare Disease Collaboration with Oddifact - Contract Pharma

Tue, 16 Jun 2026 13:48:21 GMT

Mabion Enters Rare Disease Collaboration with Oddifact Contract Pharma

ZLAB Receives Orphan Drug Designation for Zocilurtatug Pelitecan - GuruFocus

Tue, 16 Jun 2026 13:09:09 GMT

ZLAB Receives Orphan Drug Designation for Zocilurtatug Pelitecan GuruFocus

Zai Lab gains European orphan drug designation - grafa.com

Tue, 16 Jun 2026 14:02:18 GMT

Zai Lab gains European orphan drug designation grafa.com

Alkermes’ alixorexton secures FDA and EC orphan designations - Pharmaceutical Business review -

Tue, 16 Jun 2026 10:24:23 GMT

Alkermes’ alixorexton secures FDA and EC orphan designations Pharmaceutical Business review -

PAPZIMEOS keeps 83% of RRP complete responders surgery-free 3+ years - Stock Titan

Mon, 15 Jun 2026 10:40:00 GMT

PAPZIMEOS keeps 83% of RRP complete responders surgery-free 3+ years Stock Titan

Why Precigen (PGEN) Is Up 24.6% After FDA Orphan Exclusivity Win For PAPZIMEOS - simplywall.st

Mon, 15 Jun 2026 19:23:38 GMT

Why Precigen (PGEN) Is Up 24.6% After FDA Orphan Exclusivity Win For PAPZIMEOS simplywall.st

Alkermes’ alixorexton receives orphan drug designations in US, EU - Investing.com

Mon, 15 Jun 2026 11:30:18 GMT

Alkermes’ alixorexton receives orphan drug designations in US, EU Investing.com

Cross-industry white paper calls for three paradigm shifts to unlock orphan drug development - EIN Presswire

Mon, 15 Jun 2026 07:00:00 GMT

Cross-industry white paper calls for three paradigm shifts to unlock orphan drug development EIN Presswire

US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences’ Dual Signal Modulator for the Treatment of Duchenne Muscular Dystrophy - Business Wire

Tue, 09 Jun 2026 11:00:00 GMT

US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences’ Dual Signal Modulator for the Treatment of Duchenne Muscular Dystrophy Business Wire

Congress Enacts Long-Awaited Fix to Orphan Drug Exclusivity in 2026 Consolidated Appropriations Act - Spencer Fane

Thu, 19 Feb 2026 08:00:00 GMT

Congress Enacts Long-Awaited Fix to Orphan Drug Exclusivity in 2026 Consolidated Appropriations Act Spencer Fane

2026 Orphan Drugs Infographic: - evaluate.com

Tue, 17 Mar 2026 17:41:01 GMT

2026 Orphan Drugs Infographic: evaluate.com

Pharvaris N.V. (PHVS) Presents at World Orphan Drug Congress (WODC) USA 2026 - Slideshow - Seeking Alpha

Fri, 12 Jun 2026 23:13:52 GMT

Pharvaris N.V. (PHVS) Presents at World Orphan Drug Congress (WODC) USA 2026 - Slideshow Seeking Alpha

Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe - BioSpace

Mon, 15 Jun 2026 13:25:28 GMT

Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe BioSpace

Precigen gains 7 year FDA orphan drug exclusivity - grafa.com

Mon, 15 Jun 2026 14:38:37 GMT

Precigen gains 7 year FDA orphan drug exclusivity grafa.com

Alkermes (ALKS) Stock Valuation After New Orphan Drug Designation For Alixorexton - simplywall.st

Sun, 14 Jun 2026 10:21:12 GMT

Alkermes (ALKS) Stock Valuation After New Orphan Drug Designation For Alixorexton simplywall.st

Alkermes (ALKS) wins orphan drug designations in U.S. and Europe for alixorexton - Stock Titan

Mon, 15 Jun 2026 11:09:44 GMT

Alkermes (ALKS) wins orphan drug designations in U.S. and Europe for alixorexton Stock Titan

FDA Orphan Drug Status Awarded to EO2463 in Indolent Non-Hodgkin Lymphoma - Targeted Oncology

Fri, 29 May 2026 07:00:00 GMT

FDA Orphan Drug Status Awarded to EO2463 in Indolent Non-Hodgkin Lymphoma Targeted Oncology

Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging - guardonline.com

Mon, 15 Jun 2026 10:41:56 GMT

Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging guardonline.com

Evaluate Releases 2026 Orphan Drug Report - evaluate.com

Thu, 12 Mar 2026 18:17:27 GMT

Evaluate Releases 2026 Orphan Drug Report evaluate.com

World Orphan Drug Congress USA 2026: Medicaid Challenges Under the One Big Beautiful Bill Act - NAVLIN DAILY

Thu, 11 Jun 2026 19:44:28 GMT

World Orphan Drug Congress USA 2026: Medicaid Challenges Under the One Big Beautiful Bill Act NAVLIN DAILY

Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging - Jonesboro Sun

Mon, 15 Jun 2026 10:41:56 GMT

Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging Jonesboro Sun

Will Orphan Drug Status And Advancing Autoimmune Pipeline Change Dianthus Therapeutics' (DNTH) Narrative - Yahoo Finance

Wed, 10 Jun 2026 00:17:00 GMT

Will Orphan Drug Status And Advancing Autoimmune Pipeline Change Dianthus Therapeutics' (DNTH) Narrative Yahoo Finance

Alkermes receives transatlantic orphan drug designations for alixorexton - grafa.com

Mon, 15 Jun 2026 14:38:34 GMT

Alkermes receives transatlantic orphan drug designations for alixorexton grafa.com

GSK receives US and EU orphan drug designations for momelotinib in VEXAS syndrome - Investing.com

Fri, 12 Jun 2026 11:32:23 GMT

GSK receives US and EU orphan drug designations for momelotinib in VEXAS syndrome Investing.com

Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States - PR Newswire

Wed, 27 May 2026 07:00:00 GMT

Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States PR Newswire

FDA Grants Orphan Drug Designation to Tovecimig for Biliary Tract Cancer - Targeted Oncology

Thu, 09 Apr 2026 07:00:00 GMT

FDA Grants Orphan Drug Designation to Tovecimig for Biliary Tract Cancer Targeted Oncology

Tris Pharma Announces FDA Grant of Orphan Drug Designation - GlobeNewswire

Wed, 10 Jun 2026 11:30:00 GMT

Tris Pharma Announces FDA Grant of Orphan Drug Designation GlobeNewswire

Alkermes (ALKS) Receives Orphan Drug Designation for Alixorexton - GuruFocus

Thu, 11 Jun 2026 19:07:30 GMT

Alkermes (ALKS) Receives Orphan Drug Designation for Alixorexton GuruFocus

Orphan Drugs Outlook 2032: Sales, Pipeline & Policy for Rare Diseases - evaluate.com

Wed, 11 Mar 2026 18:19:52 GMT

Orphan Drugs Outlook 2032: Sales, Pipeline & Policy for Rare Diseases evaluate.com

Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging - The Joplin Globe

Mon, 15 Jun 2026 10:41:56 GMT

Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging The Joplin Globe

CLN-049 Nets FDA Orphan Drug Designation for in R/R AML - OncLive

Wed, 20 May 2026 07:00:00 GMT

CLN-049 Nets FDA Orphan Drug Designation for in R/R AML OncLive

FDA Grants Orphan Drug Designation to Eftilagimod Alfa for Soft Tissue Sarcoma - Targeted Oncology

Thu, 16 Apr 2026 07:00:00 GMT

FDA Grants Orphan Drug Designation to Eftilagimod Alfa for Soft Tissue Sarcoma Targeted Oncology

FDA Grants Orphan Drug Designation to Irinotecan Delivery Implant for High-Grade Glioma - Targeted Oncology

Thu, 19 Mar 2026 07:00:00 GMT

FDA Grants Orphan Drug Designation to Irinotecan Delivery Implant for High-Grade Glioma Targeted Oncology

Osteosarcoma Drug Earns Rare Pediatric Disease, Orphan Drug Designations - CancerNetwork

Thu, 21 May 2026 07:00:00 GMT

Osteosarcoma Drug Earns Rare Pediatric Disease, Orphan Drug Designations CancerNetwork

Zolucatetide Receives Orphan Drug Designation for Desmoid Tumors - CancerNetwork

Thu, 12 Mar 2026 07:00:00 GMT

Zolucatetide Receives Orphan Drug Designation for Desmoid Tumors CancerNetwork

Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients - PR Newswire

Wed, 22 Apr 2026 07:00:00 GMT

Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients PR Newswire

People with Medicare Will Face Higher Costs for Some Orphan Drugs Due to Changes in the New Tax and Budget Law - KFF

Mon, 20 Oct 2025 07:00:00 GMT

People with Medicare Will Face Higher Costs for Some Orphan Drugs Due to Changes in the New Tax and Budget Law KFF

FDA Grants Orphan Drug Designation to Tovecimig for Biliary Tract Cancer - CancerNetwork

Wed, 08 Apr 2026 07:00:00 GMT

FDA Grants Orphan Drug Designation to Tovecimig for Biliary Tract Cancer CancerNetwork

FDA Grants Orphan Drug Designation for Gotistobart in Squamous NSCLC - Targeted Oncology

Tue, 13 Jan 2026 08:00:00 GMT

FDA Grants Orphan Drug Designation for Gotistobart in Squamous NSCLC Targeted Oncology

Pasithea Therapeutics Announces Orphan Drug Designation by FDA of PAS-004 for Treatment of Amyotrophic Lateral Sclerosis (ALS) - Yahoo Finance

Tue, 02 Jun 2026 07:00:00 GMT

Pasithea Therapeutics Announces Orphan Drug Designation by FDA of PAS-004 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Yahoo Finance

Tinlarebant earns Swiss orphan drug status for Stargardt disease - Ophthalmology Times

Wed, 20 May 2026 07:00:00 GMT

Tinlarebant earns Swiss orphan drug status for Stargardt disease Ophthalmology Times

FDA Grants Orphan Drug Designation to Zenocutuzumab in Cholangiocarcinoma - CancerNetwork

Mon, 09 Feb 2026 08:00:00 GMT

FDA Grants Orphan Drug Designation to Zenocutuzumab in Cholangiocarcinoma CancerNetwork

FDA Grants Orphan Drug Designation to IFx-2.0 for Advanced Melanoma - Targeted Oncology

Mon, 02 Feb 2026 08:00:00 GMT

FDA Grants Orphan Drug Designation to IFx-2.0 for Advanced Melanoma Targeted Oncology

Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease - PR Newswire

Thu, 26 Mar 2026 07:00:00 GMT

Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease PR Newswire

Novel FLT3/CD3 T-Cell Engager Earns Orphan Drug Designation in R/R AML - CancerNetwork

Wed, 20 May 2026 07:00:00 GMT

Novel FLT3/CD3 T-Cell Engager Earns Orphan Drug Designation in R/R AML CancerNetwork

Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate report - Fierce Pharma

Thu, 12 Mar 2026 07:00:00 GMT

Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate report Fierce Pharma

Orphan Drugs at a Crossroads: Bigger Numbers, Tougher Calls - evaluate.com

Thu, 12 Mar 2026 07:00:00 GMT

Orphan Drugs at a Crossroads: Bigger Numbers, Tougher Calls evaluate.com

Small molecules are 'resurgent' in orphan drug R&D: Evaluate - Fierce Biotech

Thu, 12 Mar 2026 07:00:00 GMT

Small molecules are 'resurgent' in orphan drug R&D: Evaluate Fierce Biotech

Three Things we Learned in our 2026 Orphan Drugs Webinar - evaluate.com

Fri, 20 Mar 2026 07:00:00 GMT

Three Things we Learned in our 2026 Orphan Drugs Webinar evaluate.com

CLN-049 Gains FDA Orphan Drug Designation in R/R AML - Targeted Oncology

Tue, 19 May 2026 07:00:00 GMT

CLN-049 Gains FDA Orphan Drug Designation in R/R AML Targeted Oncology

FDA grants orphan drug designation to DSP-3077 for retinitis pigmentosa - Ophthalmology Times

Mon, 23 Mar 2026 07:00:00 GMT

FDA grants orphan drug designation to DSP-3077 for retinitis pigmentosa Ophthalmology Times

Latest congressional spending package includes important updates for orphan disease and pediatric drug development - www.hoganlovells.com

Tue, 10 Feb 2026 08:00:00 GMT

Latest congressional spending package includes important updates for orphan disease and pediatric drug development www.hoganlovells.com

FDA Grants Orphan Drug Status to IFx-2.0 for Advanced Melanoma Care - Cure Today

Mon, 02 Feb 2026 08:00:00 GMT

FDA Grants Orphan Drug Status to IFx-2.0 for Advanced Melanoma Care Cure Today

New Treg Therapy Earns FDA Orphan Drug Designation in Myelofibrosis - CancerNetwork

Wed, 07 Jan 2026 08:00:00 GMT

New Treg Therapy Earns FDA Orphan Drug Designation in Myelofibrosis CancerNetwork

China’s orphan drug exclusivity could bolster market, incentivize development - BioCentury

Thu, 29 Jan 2026 08:00:00 GMT

China’s orphan drug exclusivity could bolster market, incentivize development BioCentury

TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma - PR Newswire

Mon, 02 Feb 2026 08:00:00 GMT

TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma PR Newswire

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan - GlobeNewswire

Thu, 04 Jun 2026 12:30:00 GMT

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan GlobeNewswire

FDA Grants Orphan Drug Status to Irinotecan-ChemoSeed for Malignant Glioma - CancerNetwork

Wed, 18 Mar 2026 07:00:00 GMT

FDA Grants Orphan Drug Status to Irinotecan-ChemoSeed for Malignant Glioma CancerNetwork

FDA Grants Orphan Drug Designation to LP-284 for Soft Tissue Sarcoma - Cure Today

Tue, 20 Jan 2026 08:00:00 GMT

FDA Grants Orphan Drug Designation to LP-284 for Soft Tissue Sarcoma Cure Today

Enterome receives U.S. FDA Orphan Drug Designation for - GlobeNewswire

Thu, 28 May 2026 07:00:00 GMT

Enterome receives U.S. FDA Orphan Drug Designation for GlobeNewswire

Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea - GlobeNewswire

Tue, 02 Jun 2026 05:00:00 GMT

Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea GlobeNewswire

Pharma companies and patient groups seek to exempt orphan drugs from Colorado pricing limits - statnews.com

Mon, 06 Apr 2026 07:00:00 GMT

Pharma companies and patient groups seek to exempt orphan drugs from Colorado pricing limits statnews.com

Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis - Yahoo Finance

Wed, 27 May 2026 07:00:00 GMT

Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis Yahoo Finance

Japan grants orphan status to drug for rare skin disorder with no treatment - Stock Titan

Thu, 04 Jun 2026 07:00:00 GMT

Japan grants orphan status to drug for rare skin disorder with no treatment Stock Titan

CTD402 Receives Orphan Drug Designation For T-Cell Leukemia/Lymphoma - CancerNetwork

Wed, 28 Jan 2026 08:00:00 GMT

CTD402 Receives Orphan Drug Designation For T-Cell Leukemia/Lymphoma CancerNetwork

FDA Grants Orphan Drug Status to CTD402 for Rare T-Cell Blood Cancers - Cure Today

Wed, 28 Jan 2026 08:00:00 GMT

FDA Grants Orphan Drug Status to CTD402 for Rare T-Cell Blood Cancers Cure Today

FL118 Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Osteosarcoma - Roswell Park Comprehensive Cancer Center

Wed, 20 May 2026 07:00:00 GMT

FL118 Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Osteosarcoma Roswell Park Comprehensive Cancer Center

in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed - Business Wire

Tue, 02 Jun 2026 07:00:00 GMT

in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed Business Wire

Zenocutuzumab‑zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma - PR Newswire

Thu, 05 Feb 2026 08:00:00 GMT

Zenocutuzumab‑zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma PR Newswire

Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States - GlobeNewswire

Mon, 06 Apr 2026 07:00:00 GMT

Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States GlobeNewswire

FDA Grants Orphan Drug Designation to Cellenkos' CK0804 Treg Therapy for Treatment of Myelofibrosis - PR Newswire

Tue, 06 Jan 2026 08:00:00 GMT

FDA Grants Orphan Drug Designation to Cellenkos' CK0804 Treg Therapy for Treatment of Myelofibrosis PR Newswire

Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes - Targeted Oncology

Tue, 16 Dec 2025 08:00:00 GMT

Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes Targeted Oncology

LAST WEEK IN REVIEW - NAVLIN DAILY

Mon, 15 Jun 2026 12:55:23 GMT

LAST WEEK IN REVIEW NAVLIN DAILY

TSRA-196 Gets FDA Fast Track, Orphan Drug Designations for AATD - HCPLive

Mon, 23 Feb 2026 08:00:00 GMT

TSRA-196 Gets FDA Fast Track, Orphan Drug Designations for AATD HCPLive

Uttroside B, a US FDA-designated ‘Orphan Drug’, mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3 - Nature

Thu, 16 Apr 2026 07:00:00 GMT

Uttroside B, a US FDA-designated ‘Orphan Drug’, mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3 Nature

FDA Orphan Drug Designation Granted to Zavabresib for Myelofibrosis - Cure Today

Thu, 22 Jan 2026 08:00:00 GMT

FDA Orphan Drug Designation Granted to Zavabresib for Myelofibrosis Cure Today

Is Rare Disease Policy a Stress Test of US Health Care? - The American Journal of Managed Care® (AJMC®)

Tue, 03 Feb 2026 08:00:00 GMT

Is Rare Disease Policy a Stress Test of US Health Care? The American Journal of Managed Care® (AJMC®)

Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight - PR Newswire

Wed, 04 Mar 2026 08:00:00 GMT

Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight PR Newswire

Orphan drug tweak in US spending bill will make life easier for the FDA - Endpoints News

Fri, 06 Feb 2026 08:00:00 GMT

Orphan drug tweak in US spending bill will make life easier for the FDA Endpoints News

FDA Grants Orphan Drug Designation to Risvutatug Rezetecan for SCLC - OncLive

Thu, 11 Dec 2025 08:00:00 GMT

FDA Grants Orphan Drug Designation to Risvutatug Rezetecan for SCLC OncLive

FDA Grants Orphan Drug Designation to Utidelone in Pancreatic Cancer - Cure Today

Fri, 26 Sep 2025 07:00:00 GMT

FDA Grants Orphan Drug Designation to Utidelone in Pancreatic Cancer Cure Today

Mixed signals cloud the orphan drug market - Pharma Voice

Wed, 25 Mar 2026 07:00:00 GMT

Mixed signals cloud the orphan drug market Pharma Voice

PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis - Business Wire

Thu, 19 Feb 2026 08:00:00 GMT

PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis Business Wire

Congress Reauthorizes the Rare Pediatric Disease Priority Review Voucher Program and Clarifies Orphan Drug Exclusivity - Wilson Sonsini

Tue, 10 Feb 2026 08:00:00 GMT

Congress Reauthorizes the Rare Pediatric Disease Priority Review Voucher Program and Clarifies Orphan Drug Exclusivity Wilson Sonsini

SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma - Yahoo Finance

Wed, 03 Jun 2026 07:00:00 GMT

SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma Yahoo Finance

CK0804 Receives FDA Orphan Drug Designation for Myelofibrosis - OncLive

Wed, 07 Jan 2026 08:00:00 GMT

CK0804 Receives FDA Orphan Drug Designation for Myelofibrosis OncLive

Rare Disease Therapies: How Orphan Drugs Are Reshaping Global Biopharma Sourcing - PharmTech.com

Thu, 26 Feb 2026 08:00:00 GMT

Rare Disease Therapies: How Orphan Drugs Are Reshaping Global Biopharma Sourcing PharmTech.com

FDA Grants Orphan Drug Designation to Zenocutuzumab for Cholangiocarcinoma - Cure Today

Fri, 06 Feb 2026 08:00:00 GMT

FDA Grants Orphan Drug Designation to Zenocutuzumab for Cholangiocarcinoma Cure Today

AJ1-11095 Receives Orphan Drug Designation From the FDA in Myelofibrosis - OncLive

Wed, 10 Dec 2025 08:00:00 GMT

AJ1-11095 Receives Orphan Drug Designation From the FDA in Myelofibrosis OncLive

Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration - PR Newswire

Mon, 30 Mar 2026 07:00:00 GMT

Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration PR Newswire

Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy - PR Newswire

Fri, 16 Jan 2026 08:00:00 GMT

Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy PR Newswire

Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Patients Receiving a Liver Transplant - PR Newswire

Wed, 21 Jan 2026 08:00:00 GMT

Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Patients Receiving a Liver Transplant PR Newswire

Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome - GlobeNewswire

Fri, 17 Apr 2026 07:00:00 GMT

Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome GlobeNewswire

Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma - Yahoo Finance UK

Wed, 27 May 2026 07:00:00 GMT

Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma Yahoo Finance UK

Novita Pharmaceuticals Announces FDA Orphan Drug Designation Granted to NP-G2-044 for the Treatment of Pancreatic Cancer - PR Newswire

Mon, 12 Jan 2026 08:00:00 GMT

Novita Pharmaceuticals Announces FDA Orphan Drug Designation Granted to NP-G2-044 for the Treatment of Pancreatic Cancer PR Newswire

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas - GlobeNewswire

Wed, 08 Apr 2026 07:00:00 GMT

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas GlobeNewswire